Development of a redox sensitive liposome for diagnosis and treatment for liver damages
Project/Area Number |
15K07912
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Physical pharmacy
|
Research Institution | Sojo University |
Principal Investigator |
|
Co-Investigator(Renkei-kenkyūsha) |
TAKESHITA Keizo 崇城大学, 薬学部, 教授 (70175438)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2017: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2016: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2015: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
|
Keywords | レドックス / 酸化ストレス / ニトロキシルラジカル / リポソーム / in vivo ESR / MRI |
Outline of Final Research Achievements |
We synthesized a nitroxyl radical-binding phospholipid and prepared a redox sensitive liposome. It is difficult to measure the in vivo redox by an in vivo ESR technique using a nitroxyl radical in a disease model having renal impairment, because the half-life of a nitroxyl radical is short. However, we achieved increase of retention in the body of the nitroxyl radical by producing a redox sensitive liposome. This would lead to increase of target diseases of non-invasive redox measurement by ESR and MRI, because difference of probe concentration in a body between healthy and disease model animals would decrease.
|
Report
(4 results)
Research Products
(7 results)
-
-
-
[Journal Article] Surface-deacetylated chitin nanofibers reinforced with a sulfobutyl ether β-cyclodextrin gel loaded with prednisolone as potential therapy for inflammatory bowel disease.2017
Author(s)
Tabuchi R, Anraku M, Iohara D, Ishiguro T, Ifuku S, Nagae T, Uekama K, Okazaki S, Takeshita K, Otagiri M, Hirayama F.
-
Journal Title
Carbohydrate Polymers
Volume: 174
Pages: 1087-1094
DOI
Related Report
Peer Reviewed
-
-
-
-